MUSCLE RELAXANT AND ANALGESIC CAPLETS TABLET

Quốc gia: Canada

Ngôn ngữ: Tiếng Anh

Nguồn: Health Canada

Thành phần hoạt chất:

IBUPROFEN; METHOCARBAMOL

Sẵn có từ:

INTERNATIONAL PHARMACEUTICAL GENERICS LTD

Mã ATC:

M03BA53

INN (Tên quốc tế):

METHOCARBAMOL, COMBINATIONS EXCL PSYCHOLEPTICS

Liều dùng:

200MG; 500MG

Dạng dược phẩm:

TABLET

Thành phần:

IBUPROFEN 200MG; METHOCARBAMOL 500MG

Tuyến hành chính:

ORAL

Các đơn vị trong gói:

100

Loại thuốc theo toa:

OTC

Khu trị liệu:

CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS

Tóm tắt sản phẩm:

Active ingredient group (AIG) number: 0248961001; AHFS:

Tình trạng ủy quyền:

CANCELLED PRE MARKET

Ngày ủy quyền:

2017-06-13

Đặc tính sản phẩm

1 | P a g e
PRODUCT MONOGRAPH
MUSCLE RELAXANT & ANALGESIC CAPLETS
500 MG METHOCARBAMOL AND 200 MG IBUPROFEN TABLETS
THERAPEUTIC CLASSIFICATION
MUSCLE RELAXANT / ANALGESIC
INTERNATIONAL PHARMACEUTICAL GENERICS LTD.,
Date of Preparation:
30 Malta Avenue, Suite 2408
February 01, 2010
Brampton, ON
L6Y 4S5
Control#: 135919
2 | P a g e
TABLE
OF CONTENTS
Clinical
Pharmacology..............................................................................................................................3
Indications:................................................................................................................................................7
Contraindications
......................................................................................................................................8
Warnings:..................................................................................................................................................8
Precautions..............................................................................................................................................12
Drug Interactions
....................................................................................................................................13
Adverse Reactions
..................................................................................................................................15
Symptoms and Treatment of
Overdose...................................................................................................17
Dosage and
Administration.....................................................................................................................18
Pharmaceutical
Information....................................................................................................................19
Composition:...........................................................................................................................................21
Availability of Dosage
Forms............